Oncology Business Management

Last Wednesday, the House of Representatives voted on the Consolidated Appropriations Act of 2014, with the Senate passing the bill last night.

Harnessing multiple components of the immune system to fight cancer is the focus of NewLink Genetics' clinical pipeline.

The Office of the National Coordinator for Health Information Technology has released a set of guides and interactive tools to help medical practices improve their use of electronic health records.

The Centers for Medicare & Medicaid Services will make public a once previously confidential database of Medicare claims.

As fee-for-service models dwindle under healthcare reform, new reimbursement models based on risk are emerging.

A survey of 46 representatives from accountable care organizations (ACOs) indicates that critical gaps remain in the organizations' ability to support, manage, and ensure appropriate medication use.

Patient care is shifting from inpatient to outpatient settings, especially in oncology.

The FDA has granted an accelerated approval to the combination of the MEK inhibitor trametinib and the BRAF inhibitor dabrafenib as a treatment for patients with unresectable or metastatic melanoma that harbors a BRAF V600E or V600K mutation.

With the October deadline for ICD-10 transition looming, now might be the time to consider integrating current electronic health records systems with clinically-driven revenue cycle management (RCM) software.

The FDA's rules for approving new drugs for the treatment of women with ovarian cancer pose frustrating problems for researchers developing novel agents and for clinicians seeking to improve outcomes for their patients

The transition to ICD-10 is likely to cost your practice both time and money, making a smooth implementation process all the more important.

San Diego-based Ambit Biosciences is staking its success on the kinome, a set of protein kinases in the genome and an important source for targeted therapies in oncology.

Provider-based research networks (PBRNs) make clinical trials available to community-based practices.

Although the changeover to using ICD-10 billing codes won't be mandatory until October 1, 2014, there are many coding changes to consider starting on January 1. Specifically, the reimbursement rate for some genetic testing and imaging involving breast cancer will see significant changes.

As new cancer therapies have prolonged life, an interesting question has arisen among community oncologists: "Is it better to transfer long-term cancer survivors to general practitioners or develop clinics for long-term survivors within cancer centers?"

The US Supreme Court's decision to uphold the Affordable Care Act but allow states to decide whether to expand Medicaid has raised a question in many states: Where political leaders have been opposed or split on President Obama's healthcare reforms, is it smart or foolish to cover more people?

The first oncology-specific accountable care organization (ACO) reported more than a 2% savings in its first year of existence.